298 related articles for article (PubMed ID: 19951314)
21. [Thrombocytapheresis with the new PLT-30 collection chamber in the CS 3000 Plus cell separator].
Moog R; Müller N
Beitr Infusionsther Transfusionsmed; 1994; 32():323-4. PubMed ID: 9480118
[TBL] [Abstract][Full Text] [Related]
22. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
[TBL] [Abstract][Full Text] [Related]
24. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
Fontana S; Rados L; Schmid P; Leibundgut EO; Taleghani BM
Transfusion; 2011 Sep; 51(9):2034-43. PubMed ID: 21438883
[TBL] [Abstract][Full Text] [Related]
25. Platelet function in variable platelet split products intended for neonatal transfusion.
Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
[TBL] [Abstract][Full Text] [Related]
26. Blood component collection by apheresis.
Burgstaler EA
J Clin Apher; 2006 Jul; 21(2):142-51. PubMed ID: 15880369
[TBL] [Abstract][Full Text] [Related]
27. The selection of donors in multicomponent collection management.
Bonomo P; Garozzo G; Bennardello F
Transfus Apher Sci; 2004 Feb; 30(1):55-9. PubMed ID: 14746822
[TBL] [Abstract][Full Text] [Related]
28. The content of the LRS chamber provides a new quality tool for the characterization of the donor platelet profile.
Vasconcelos E; Sousa AP; Seghatchian J; Maurício R; Figueiredo AC; Leitão C; Sousa G
Transfus Apher Sci; 2005 Apr; 32(2):221-5. PubMed ID: 15784457
[TBL] [Abstract][Full Text] [Related]
29. Automated programs for collection of mononuclear cells and progenitor cells by two separators for peripheral blood progenitor cell transplantation: comparison by a randomized crossover study.
Ikeda K; Ohto H; Kanno T; Ogata T; Noji H; Ogawa K; Maruyama Y
Transfusion; 2007 Jul; 47(7):1234-40. PubMed ID: 17581158
[TBL] [Abstract][Full Text] [Related]
30. Influence of multicomponent apheresis on donors' haematological and coagulation parameters, iron storage and platelet function.
Macher S; Sipurzynski-Budraβ S; Rosskopf K; Semmelrock M; Prüller F; Griesbacher A; Lanzer G; Schallmoser K
Vox Sang; 2012 Oct; 103(3):194-200. PubMed ID: 22471611
[TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
32. Concentration changes to counteract the effects of bacteriological sampling on PLT yields.
Burgstaler EA; Mako AM; Winters JL
J Clin Apher; 2008; 23(2):74-81. PubMed ID: 18366087
[TBL] [Abstract][Full Text] [Related]
33. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
[TBL] [Abstract][Full Text] [Related]
34. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions.
Eder AF; Dy BA; DeMerse B; Wagner SJ; Stramer SL; O'Neill EM; Herron RM
Transfusion; 2017 Dec; 57(12):2969-2976. PubMed ID: 28880363
[TBL] [Abstract][Full Text] [Related]
35. Practical issues that should be considered when planning the implementation of pathogen reduction technology for plateletpheresis.
Jimenez-Marco T; Mercant C; Lliteras E; Cózar M; Girona-Llobera E
Transfus Apher Sci; 2015 Feb; 52(1):84-93. PubMed ID: 25554212
[TBL] [Abstract][Full Text] [Related]
36. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
Méndez A; Wägli F; Schmid I; Frey BM
Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
[TBL] [Abstract][Full Text] [Related]
37. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
Alex J; Roberts B; Raife T
J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
[TBL] [Abstract][Full Text] [Related]
38. Comparison of plateletpheresis with two different cell separators using 100 identical donors.
Wiesneth M; Freudenberg J; Platow S; Kalinova J; Vogel M; Kubanek B
Beitr Infusionsther; 1991; 28():201-3. PubMed ID: 1725619
[TBL] [Abstract][Full Text] [Related]
39. Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators.
Perseghin P; Mascaretti L; Speranza T; Belotti D; Baldini V; Dassi M; Riva M; Pogliani EM; Sciorelli G
Transfusion; 2004 Jan; 44(1):125-30. PubMed ID: 14692978
[TBL] [Abstract][Full Text] [Related]
40. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
Zeiler T; Gritzka D; Karger R; Kretschmer V
Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
